Bioactivity:

BY27 is a potent and selective BET BD2 inhibitor (Ki: 3.1 nM) with anti-cancer activity and shows 38, 5, 7, and 21-fold BD1/BD2 selectivity for BRD2, BRD3, BRD4, and BRDT.

CAS nr:

2247236-59-3

Purity:

98%

Molecular Weight:

404,9

SMILES:

CN1N=CC(C2=CC=C(N3C(CC[C@H]4NC5=CC=C(Cl)C=C5)=NN=C3C)C4=C2)=C1

Formula:

C22H21ClN6

Pathway:

Others

Target:

Others